| Dr Lakshmi Kumari Yella, MD | |
|
120 New York Ave, Suite 6w, Huntington, NY 11743 | |
| (631) 351-1144 | |
| (631) 351-1143 |
| Full Name | Dr Lakshmi Kumari Yella |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 41 Years |
| Location | 120 New York Ave, Huntington, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750458089 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 237682 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amityville Pulmonology Pllc | 2567471139 | 9 |
News Archive
The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.
News outlets analyze how health policy positions taken by GOP presidential hopeful Mitt Romney and President Barack Obama are playing on the campaign trail.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 6 days ago
| Entity Name | North Shore Medical Group Of The Mount Sinai School Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275640609 PECOS PAC ID: 8921999087 Enrollment ID: O20040320000412 |
News Archive
The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.
News outlets analyze how health policy positions taken by GOP presidential hopeful Mitt Romney and President Barack Obama are playing on the campaign trail.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 6 days ago
| Entity Name | Huntington Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386619385 PECOS PAC ID: 1850296427 Enrollment ID: O20040426001035 |
News Archive
The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.
News outlets analyze how health policy positions taken by GOP presidential hopeful Mitt Romney and President Barack Obama are playing on the campaign trail.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 6 days ago
| Entity Name | Amityville Pulmonology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154423622 PECOS PAC ID: 2567471139 Enrollment ID: O20060410000225 |
News Archive
The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.
News outlets analyze how health policy positions taken by GOP presidential hopeful Mitt Romney and President Barack Obama are playing on the campaign trail.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 6 days ago
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.
News outlets analyze how health policy positions taken by GOP presidential hopeful Mitt Romney and President Barack Obama are playing on the campaign trail.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lakshmi Kumari Yella, MD 120 New York Ave, Huntington, NY 11743 Ph: (631) 351-1144 | Dr Lakshmi Kumari Yella, MD 120 New York Ave, Suite 6w, Huntington, NY 11743 Ph: (631) 351-1144 |
News Archive
The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.
News outlets analyze how health policy positions taken by GOP presidential hopeful Mitt Romney and President Barack Obama are playing on the campaign trail.
Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today positive topline clinical results from a 6-week randomized, double-masked, placebo-controlled Phase 1b/2a study of EBI-005 in patients with dry eye disease.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2011.
University of Granada and the Spanish Consejo Superior de Investigaciones Cient-ficas (CSIC) researchers will use nanoscopic clay for the controlled release of drugs in patients, with the aim of designing more efficient and less toxic drugs. This is a pilot research study that includes CSIC and University of Granada researchers and researchers from other institutions.
› Verified 6 days ago
Richard B Schwarz, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 325 Park Ave, Huntington, NY 11743 Phone: 631-351-3784 Fax: 631-547-5349 | |
Dr. Sotir Polena, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 172 E Main St, Huntington, NY 11743 Phone: 631-385-0022 Fax: 631-385-0896 | |
Dr. James I Klepper, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 175 E Main St, Suite 200, Huntington, NY 11743 Phone: 631-549-5700 Fax: 631-549-1991 | |
Dr. Adam Ross Davis, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 172 E Main St, Huntington, NY 11743 Phone: 631-385-0022 Fax: 631-385-0896 | |
Dr. Jalil Anwar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 161 E Main St, Huntington, NY 11743 Phone: 631-760-8207 Fax: 631-549-1084 | |
Frederick Joseph Gandolfo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 205 E Main St Ste 1-4, Huntington, NY 11743 Phone: 631-350-6077 | |
Ritsa Marie Frousios, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2000 |